Lipum AB (publ) (LIPUM.ST)

SEK 13.3

(-1.48%)

Total Debt Summary of Lipum AB (publ)

  • Lipum AB (publ)'s latest annual total debt in 2023 was 1.76 Million SEK , up 6.02% from previous year.
  • Lipum AB (publ)'s latest quarterly total debt in 2024 Q1 was 1.76 Million SEK , down 0.0% from previous quarter.
  • Lipum AB (publ) reported annual total debt of 1.66 Million SEK in 2022, up 6.07% from previous year.
  • Lipum AB (publ) reported annual total debt of 1.56 Million SEK in 2021, up 6.06% from previous year.
  • Lipum AB (publ) reported quarterly total debt of 1.76 Million SEK for 2024 Q2, down 0.0% from previous quarter.
  • Lipum AB (publ) reported quarterly total debt of 1.76 Million SEK for 2024 Q1, down 0.0% from previous quarter.

Annual Total Debt Chart of Lipum AB (publ) (2023 - 2017)

Historical Annual Total Debt of Lipum AB (publ) (2023 - 2017)

Year Total Debt Total Debt Growth
2023 1.76 Million SEK 6.02%
2022 1.66 Million SEK 6.07%
2021 1.56 Million SEK 6.06%
2020 1.47 Million SEK 0.0%
2019 - SEK 0.0%
2018 - SEK 0.0%
2017 - SEK 0.0%

Peer Total Debt Comparison of Lipum AB (publ)

Name Total Debt Total Debt Difference
Alligator Bioscience AB (publ) 16.09 Million SEK 89.06%
Ziccum AB (publ) 857 Thousand SEK -105.484%
Modus Therapeutics Holding AB (publ) - SEK -Infinity%
BioArctic AB (publ) 4.97 Million SEK 64.631%
Sprint Bioscience AB (publ) - SEK -Infinity%
Mendus AB (publ) 24.48 Million SEK 92.809%
Genovis AB (publ.) 79.32 Million SEK 97.78%
Intervacc AB (publ) 181 Thousand SEK -872.928%
QuiaPEG Pharmaceuticals Holding AB (publ) 20.61 Million SEK 91.456%
Active Biotech AB (publ) 3 Million SEK 41.3%
Magle Chemoswed Holding AB (publ) 60.3 Million SEK 97.08%
Bio-Works Technologies AB (publ) - SEK -Infinity%
Aptahem AB (publ) 5 Million SEK 64.78%
Vicore Pharma Holding AB (publ) - SEK -Infinity%
Kancera AB (publ) - SEK -Infinity%
Infant Bacterial Therapeutics AB (publ) - SEK -Infinity%
Fluicell AB (publ) - SEK -Infinity%
Saniona AB (publ) 71.4 Million SEK 97.534%
Lipigon Pharmaceuticals AB (publ) - SEK -Infinity%
Biovica International AB (publ) 7.82 Million SEK 77.504%
Spago Nanomedical AB (publ) - SEK -Infinity%
AcouSort AB (publ) - SEK -Infinity%
Xintela AB (publ) - SEK -Infinity%
Abliva AB (publ) 424 Thousand SEK -315.33%
Egetis Therapeutics AB (publ) 108.6 Million SEK 98.378%
Karolinska Development AB (publ) 3.07 Million SEK 42.638%
OncoZenge AB (publ) - SEK -Infinity%
Amniotics AB (publ) 2.58 Million SEK 31.744%
2cureX AB (publ) - SEK -Infinity%
CombiGene AB (publ) - SEK -Infinity%
Asarina Pharma AB (publ) 1 Million SEK -76.1%
Calliditas Therapeutics AB (publ) 979.13 Million SEK 99.82%
Camurus AB (publ) 24.5 Million SEK 92.814%
Corline Biomedical AB - SEK -Infinity%
IRLAB Therapeutics AB (publ) 27.56 Million SEK 93.612%
Isofol Medical AB (publ) - SEK -Infinity%
I-Tech AB - SEK -Infinity%
Hansa Biopharma AB (publ) 866.76 Million SEK 99.797%
Cyxone AB (publ) 858 Thousand SEK -105.245%
ExpreS2ion Biotech Holding AB (publ) 1.71 Million SEK -2.922%
Biosergen AB - SEK -Infinity%
Cantargia AB (publ) - SEK -Infinity%
NextCell Pharma AB - SEK -Infinity%
Xspray Pharma AB (publ) 36.8 Million SEK 95.216%
Elicera Therapeutics AB (publ) - SEK -Infinity%
Nanologica AB (publ) 666 Thousand SEK -164.414%
SynAct Pharma AB 637 Thousand SEK -176.452%
Annexin Pharmaceuticals AB (publ) - SEK -Infinity%
Stayble Therapeutics AB (publ) 850 Thousand SEK -107.176%
LIDDS AB (publ) - SEK -Infinity%
BioInvent International AB (publ) 23.24 Million SEK 92.424%
Alzinova AB (publ) 800 Thousand SEK -120.125%
Oncopeptides AB (publ) 106.48 Million SEK 98.346%
Pila Pharma AB (publ) 773.08 Thousand SEK -127.79%
Guard Therapeutics International AB (publ) - SEK -Infinity%
Scandinavian ChemoTech AB (publ) - SEK -Infinity%
Simris Alg AB (publ) 90.74 Million SEK 98.059%
Diamyd Medical AB (publ) 30.67 Million SEK 94.259%
Xbrane Biopharma AB (publ) 231.47 Million SEK 99.239%
Ascelia Pharma AB (publ) 1.06 Million SEK -65.975%
Diagonal Bio AB (publ) - SEK -Infinity%